Bank of America
LIPO

Bank of America’s Lipella Pharmaceuticals LIPO Stock Holding History

Bank of America’s Portfolio LIPO Stock Details LIPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$18 – 8555
2025
Q1 		$18 Hold
7
– – ﹤0.01% 8155
2024
Q4 		$21 Buy
7
+1
+17% +$3 ﹤0.01% 8014
2024
Q3 		$22 Hold
6
– – ﹤0.01% 7957
2024
Q2 		$21 Buy
+6
New +$33 ﹤0.01% 7999

Bank of America's LIPO Position: Q2 2025 in Review

Bank of America sold out of Lipella Pharmaceuticals (LIPO) in Q2 2025, closing a stake of 7 shares — an estimated $18 sold.

Bank of America first reported a position in LIPO in Q2 2024 and held it in 4 quarters. The position peaked at $22 in Q3 2024. 0 funds tracked by Wall St. Rank hold LIPO as of Q2 2025.

  • Bank of America reported no remaining Lipella Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 7 Lipella Pharmaceuticals shares in Q2 2025, an estimated $18.
  • Bank of America first reported a position in Lipella Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Bank of America's Lipella Pharmaceuticals position peaked at $22 in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.